Myriad Genetics Inc. | Cash Flow
Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
176,225.00
80,200.00
125,300.00
20,500.00
131,100.00
Depreciation, Depletion & Amortization
13,819.00
25,000.00
26,700.00
48,300.00
54,400.00
Other Funds
11,143.00
3,400.00
-
600.00
42,400.00
Funds from Operations
250,186.00
181,200.00
231,700.00
141,000.00
137,500.00
Changes in Working Capital
59,973.00
40,700.00
65,400.00
34,800.00
21,600.00
Net Operating Cash Flow
190,213.00
140,500.00
166,300.00
106,200.00
115,900.00
Capital Expenditures
14,271.00
23,900.00
5,000.00
6,100.00
8,400.00
Sale of Fixed Assets & Businesses
-
-
-
-
500.00
Purchase/Sale of Investments
3,396.00
64,800.00
49,400.00
75,900.00
3,200.00
Net Investing Cash Flow
17,667.00
40,900.00
91,400.00
146,300.00
11,100.00
Issuance/Reduction of Debt, Net
-
-
-
98,000.00
90,000.00
Net Financing Cash Flow
211,798.00
177,300.00
68,300.00
71,800.00
95,500.00
Net Change in Cash
39,252.00
700.00
4,400.00
33,900.00
8,500.00
Free Cash Flow
175,942.00
116,600.00
161,300.00
100,100.00
107,500.00
Deferred Taxes & Investment Tax Credit
8,124.00
400.00
18,100.00
800.00
23,500.00
Net Assets from Acquisitions
-
-
37,000.00
216,100.00
-
Change in Capital Stock
222,941.00
180,700.00
68,300.00
25,600.00
36,900.00
Exchange Rate Effect
-
4,800.00
2,200.00
2,200.00
800.00
About Myriad Genetics
View Profile
